The FDA has slated December 9th for ruling on whether to approve Benlysta, the first drug treatment for lupus in over 50 years.
"The committee's 13 to 2 vote in favor of Benlysta bodes well for the
first treatment designed for systemic lupus in more than 50 years as it
goes to federal regulators for final consideration. The FDA does not
have to follow the panel's recommendation, but often does. The agency is
slated to rule by Dec. 9"
Read more by clicking on the link below
